Search results
Author(s):
Pier D Lambiase
,
Joseph De Bono
,
Martin Lowe
,
et al
Added:
3 years ago
Heart rhythm consultants, primary care physicians, specialist registrars, nurses and physiologists may be requested to review ECGs or advise on cases where antipsychotic-induced QT prolongation is suspected or evident. The British Heart Rhythm Society has issued the Clinical Practice Guidelines on the Management of Patients Developing QT Prolongation on Antipsychotic Medication to support them…
View more
Author(s):
Serge Sicouri
,
Charles Antzelevitch
Added:
3 years ago
The link between sudden unexplained death in individuals with mental health problems who are administered antipsychotic drugs has been recognised for over a century.1 A clear relationship has emerged over the past 25 years between antipsychotic drugs, prolongation of the QT interval of the ECG, atypical polymorphic tachycardia known as torsade de pointes (TdP) and sudden cardiac death (SCD). A…
View more
Author(s):
Nabil El-Sherif
,
Gioia Turitto
,
Mohamed Boutjdir
Added:
3 years ago
Since its initial description by Jervell and Lange-Nielsen in 1957,1 congenital long QT syndrome (LQTS) has been the most investigated cardiac ion channelopathy. A prolonged QT interval on the surface ECG is a surrogate measure of prolonged ventricular action potential duration (APD).
Congenital as well as acquired alterations in certain cardiac ion channels can affect their currents in such a…
View more
Author(s):
James Ip
Added:
1 year ago
Dr James Ip (Weill Cornell Medical College, New York, NY, US) joins us in a short interview from HRS 2022 to discuss the long-term findings from the NODE-302 study. This trial aimed to evaluate the effectiveness and safety of self-administered etripamil nasal spray in patients with an episode of paroxysmal supraventricular tachycardia in an outpatient setting.
Discussion points:
1. Aims of the…
View more
Chan Hong
Job title: Pharmacist
Author
Author(s):
Cecilia Linde
Added:
1 year ago
In this short interview, Dr Cecilia Linde (Karolinska University, SE) shares the findings of the CCM HFpEF Study.
Originally presented at Heart Failure 22, this study aimed to evaluate the safety and efficacy of
cardiac contractility modulation therapy in heart failure patients with preserved ejection fraction (HFpEF).
Discussion Points:
1. Study Background
2. Study Design & Patient Population
3…
View more
David DeLurgio
Research Area(s) / Expertise:
Job title: Director of Electrophysiology
Author
Author(s):
George D Dangas
Added:
2 years ago
In this short video, Dr George Dangas (Mount Sinai Hospital, New York, NY, US) shares the findings from the ENVISAGE-TAVI AF hot line trial presented at ESC Congress 2021.
ENVISAGE-TAVI AF (Daiichi-Sankyo) compared the safety and efficacy of the DOAC edoxaban with VKAs (warfarin and its analogues) in atrial fibrillation patients with an indication for oral anticoagulation after successful TAVI.
…
View more
Izabella Uchmanowicz
Research Area(s) / Expertise:
Job title: Professor
Author
Author(s):
Jorge E Romero
,
Dan L Li
,
Ricardo Avendano
,
et al
Added:
3 years ago
Brugada syndrome (BrS), one of the most common causes of sudden cardiac death (SCD) in normal structural heart individuals, is a young entity in modern medicine. BrS was first characterised in 1992 by Brugada et al. as a distinct syndrome with “right bundle branch block, persistent ST elevation in precordial leads V1 to V2–3 and sudden cardiac death”.1 The true prevalence of BrS is not clearly…
View more